Mikael Hagstroem has been named as the company’s new CEO.
LabVantage Solutions, a laboratory informatics solutions and services provider, announced on March 25, 2021 that it has named Mikael Hagstroem as its new CEO.
Before taking on his new role, Hagstroem served as CEO and president at MetricStream, an independent provider of governance, risk, and compliance products and solutions; partner at McKinsey & Company and chief operating officer of McKinsey Analytics; and executive vice-president of the SAS Institute and president of SAS International, LabVantage said in a company press release. Additionally, Hagstroem is currently on the board of advisors of the Artificial Intelligence (AI) Forum and has served as chair of the World Economic Forum’s Global Agenda Council on Data-Driven Development, as a member of the executive committee of the US Council for International Business, and as an executive board member of the Atlantic Council.
“[Hagstroem] embodies the sense of purpose and passion required to tackle big goals and the expertise to achieve them,” said Purnendu Chatterjee, chairman of LabVantage Solutions, in the press release. “He is an accomplished business leader who has built innovative data-based enterprises across a range of industries. He is a visionary strategist who understands the transformational potential of advanced technologies and translates them into actionable business initiatives. An inspired leader, [Hagstroem] is committed to accelerating the use of new tools such as analytics and AI to address urgent global problems. We are thrilled to welcome him to LabVantage and excited at the prospect of what we can accomplish together.”
“LabVantage brings the Fourth Industrial Revolution–characterized as a range of new technologies that are fusing the physical, digital, and biological worlds and impacting all disciplines, economies, and industries–to the lab, and I am honored to take the helm,” Hagstroem added in the press release.
Source: LabVantage
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.